SEGAs are tumors frequently arising in patients with tuberous sclerosis complex that have activated mTORC1 signaling due to mutations frequently affecting the TSC1 or TSC2 genes (Figure S1) [34]. Here, TSC2 is linked to tuberous sclerosis.